Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 66.21B | 64.11B | 57.09B | 51.60B | 50.65B | 41.93B |
Gross Profit | 16.28B | 15.10B | 7.67B | 6.66B | 14.01B | 13.27B |
EBITDA | 8.24B | 6.72B | 735.00M | -648.00M | 7.88B | 7.81B |
Net Income | 5.82B | 4.67B | -188.00M | -1.29B | 1.61B | 5.58B |
Balance Sheet | ||||||
Total Assets | 115.89B | 111.62B | 103.36B | 97.99B | 99.44B | 125.99B |
Cash, Cash Equivalents and Short-Term Investments | 10.63B | 5.24B | 5.87B | 4.91B | 4.77B | 7.12B |
Total Debt | 8.09B | 8.09B | 7.94B | 7.96B | 7.98B | 7.83B |
Total Liabilities | 91.89B | 90.25B | 85.73B | 80.63B | 74.31B | 95.77B |
Stockholders Equity | 24.02B | 21.44B | 17.77B | 17.49B | 25.18B | 30.22B |
Cash Flow | ||||||
Free Cash Flow | 8.54B | 8.72B | 3.96B | 4.70B | 4.77B | 5.18B |
Operating Cash Flow | 8.74B | 8.93B | 4.23B | 5.12B | 5.12B | 5.49B |
Investing Cash Flow | -6.86B | -8.25B | -3.00B | -1.73B | 510.00M | -3.44B |
Financing Cash Flow | -1.40B | -697.00M | -1.24B | -3.42B | -5.24B | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $27.19B | 16.32 | 20.63% | 2.20% | 11.41% | 15.32% | |
82 Outperform | $53.61B | 9.57 | 27.33% | 1.93% | 9.81% | 94.71% | |
81 Outperform | $61.13B | 12.01 | 19.29% | 1.57% | 8.54% | 43.51% | |
80 Outperform | $144.83B | 13.91 | 37.29% | 1.98% | 21.50% | 51.86% | |
78 Outperform | $109.67B | 12.14 | 14.10% | 1.35% | 6.74% | -4.05% | |
78 Outperform | $24.02B | 13.33 | 13.44% | 2.19% | 9.64% | -15.08% | |
68 Neutral | $17.93B | 11.86 | 10.28% | 3.71% | 9.75% | 1.60% |
Allstate has released its June 2025 monthly report detailing estimated catastrophe losses and policies in force, which is available on their investor website. This announcement provides stakeholders with insights into the company’s financial impact from recent events and its operational status.
On July 1, 2025, Allstate announced the completion of the sale of its group health business, a move that was previously disclosed. This transaction marks a significant shift in Allstate’s operational focus, potentially impacting its market positioning and stakeholder interests.
In May 2025, Allstate released its monthly report detailing estimated catastrophe losses and the number of policies in force. This announcement is significant as it provides insights into the company’s financial health and operational resilience, which are crucial for stakeholders assessing Allstate’s market positioning and future prospects.
On May 29, 2025, Allstate held its annual stockholders meeting, where key decisions were made regarding the company’s governance and financial oversight. Thirteen directors were elected for terms expiring at the 2026 meeting, and the compensation of named executives was approved by a majority vote. Additionally, Deloitte & Touche LLP was ratified as the independent registered public accountant for 2025, reflecting continued confidence in their financial auditing capabilities.